Related Experiment Video
Updated: Aug 7, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism
1Proteomics Laboratory, Department of Experimental Oncology and Lab. Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milan Italy.
Abstract:
We report the identification of proteins induced in response to RET/PTC2, an oncogene implicated in thyroid cancers. Anti-phosphotyrosine antibody affinity resin was used to purify Tyr(P)-containing and interacting proteins from 293T and NIH3T3 cells which were transfected with kinase active or inactive RET/PTC and RETMEN2 oncogenes. Proteins were separated by one-dimensional SDS-PAGE, extracted by in-gel digestion, and identified by MALDI-TOF peptide mass fingerprinting. The expression and tyrosine phosphorylation of Sam68, a protein implicated in mRNA nucleocytoplasmic translocation and splicing, were further examined in RET-transfected cells and thyroid tumors. Of relevance, cells transfected with RETMEN2B examined for anti-phosphotyrosine bound proteins, showed other proteins implicated in splicing: DEAD-box p68 RNA helicase, SYNCRIP, and hnRNP K. Western blotting analysis suggested that these proteins are singularly tyrosine phosphorylated in RETMEN2B-transfected cells, and that they constitutively bind with Sam68. The study concludes that regulation of splicing factors is likely to be important in RET-mediated thyroid carcinogenesis.
Insights
This study identifies proteins regulated by the RET/PTC2 oncogene in thyroid cancer. Key splicing factors like Sam68 are tyrosine phosphorylated and interact, suggesting their role in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- RET/PTC2 oncogene is implicated in thyroid cancers.
- Understanding protein interactions in RET-mediated carcinogenesis is crucial.
Purpose of the Study:
- Identify proteins induced by RET/PTC2.
- Investigate the role of splicing factors in RET-mediated thyroid cancer.
Main Methods:
- Used anti-phosphotyrosine antibody affinity purification.
- Separated and identified proteins via SDS-PAGE and MALDI-TOF peptide mass fingerprinting.
- Examined protein expression and phosphorylation using Western blotting.
Main Results:
- Identified tyrosine-phosphorylated proteins interacting with RET/PTC2.
- Sam68, p68 RNA helicase, SYNCRIP, and hnRNP K were identified as key splicing factors.
- These factors showed tyrosine phosphorylation and constitutive binding with Sam68 in RETMEN2B-transfected cells.
Conclusions:
- Regulation of splicing factors is likely important in RET-mediated thyroid carcinogenesis.
- These findings provide insights into molecular mechanisms of thyroid cancer.
Related Concept Videos
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...

